In last trading session, iBio Inc (NASDAQ:IBIO) saw 2.43 million shares changing hands with its beta currently measuring 0.94. Company’s recent per share price level of $0.71 trading at -$0.02 or -2.74% at ring of the bell on the day assigns it a market valuation of $11.52M. That closing price of IBIO’s stock is at a discount of -870.42% from its 52-week high price of $6.89 and is indicating a premium of 9.86% from its 52-week low price of $0.64. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 9.92 million shares which gives us an average trading volume of 2.59 million if we extend that period to 3-months.
For iBio Inc (IBIO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
iBio Inc (NASDAQ:IBIO) trade information
Upright in the red during last session for losing -2.74%, in the last five days IBIO remained trading in the red while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $0.71 price level, adding 31.73% to its value on the day. iBio Inc’s shares saw a change of -66.03% in year-to-date performance and have moved -21.11% in past 5-day. iBio Inc (NASDAQ:IBIO) showed a performance of -12.19% in past 30-days. Number of shares sold short was 0.83 million shares which calculate 1.75 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 3.6 to the stock, which implies a rise of 80.28% to its current value. Analysts have been projecting 3.6 as a low price target for the stock while placing it at a high target of 3.6. It follows that stock’s current price would drop -407.04% in reaching the projected high whereas dropping to the targeted low would mean a loss of -407.04% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 57.55% during past 5 years.
iBio Inc (NASDAQ:IBIO)’s Major holders
Insiders are in possession of 4.31% of company’s total shares while institution are holding 15.78 percent of that, with stock having share float percentage of 16.49%. Investors also watch the number of corporate investors in a company very closely, which is 15.78% institutions for iBio Inc that are currently holding shares of the company. LYNX1 CAPITAL MANAGEMENT LP is the top institutional holder at IBIO for having 0.6 million shares of worth $1.27 billion. And as of 2024-06-30, it was holding 6.9576 of the company’s outstanding shares.
The second largest institutional holder is IKARIAN CAPITAL, LLC, which was holding about 0.6 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.9576 of outstanding shares, having a total worth of $1.27 million.
